The role of elagolix in ovulation suppression during controlled ovarian stimulation: a retrospective cohort study
Objective: To compare in vitro fertilization treatment outcomes for the oral gonadotropin-releasing hormone (GnRH) antagonist elagolix (E) to the conventionally used injectable GnRH antagonist ganirelix (G) for achieving pituitary gonadotropin suppression during a controlled ovarian stimulation (COS...
Saved in:
Main Authors: | David Soliman, M.Sc., Rita Naoom, B.Sc., Mohamed Zaied, B.Sc., Samuel Soliman, M.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | F&S Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666334124000771 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Controlled Ovarian Stimulation Protocols on IVF Outcome in Normal and Poor Responders
by: Deniz Esinler, et al.
Published: (2013-12-01) -
GnRH Peptide Antagonist: Comparative Analysis of Chemistry and Formulation with Implications for Clinical Safety and Efficacy
by: Shikha Patel, et al.
Published: (2024-12-01) -
Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2013-12-01) -
Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles
by: Berfu Demir, et al.
Published: (2016-05-01) -
Ovarian sensitivity index affects clinical pregnancy and live birth rates in gonadotropin-releasing hormone agonist and antagonist in vitro fertilization cycles
by: Chao Chin Hsu, et al.
Published: (2024-12-01)